Table 2.
Univariate GEE*ϕ analysis of sociodemographic, behavioural and clinical factors associated with ≥ 95% ART adherence.
| Variable | OR | (95% CI) | p-value |
|---|---|---|---|
| Gender | |||
| (Female vs. Male) | 0.69 | (0.52-0.90) | 0.006 |
| Age | |||
| (<24 yrs vs. ≥ 24 yrs) | 0.16 | (0.08-0.31) | <0.001 |
| Ethnicity | |||
| (Aboriginal vs. other) | 0.97 | (0.74-1.28) | 0.841 |
| Heroin use* | |||
| (Daily vs. not daily) | 0.38 | (0.30-0.48) | <0.001 |
| Cocaine use* | |||
| (Daily vs. not daily) | 0.48 | (0.40-0.57) | <0.001 |
| Crack use* | |||
| (Daily vs. not daily) | 0.94 | (0.78-1.13) | 0.509 |
| Methadone treatment | |||
| (Yes vs. no) | 2.44 | (2.01-2.96) | <0.001 |
| Other addiction treatment† | |||
| (Yes vs. no) | 1.50 | (1.26-1.79) | <0.001 |
| Education | |||
| (less than highschool vs. other) | 0.56 | (0.37-0.85) | 0.007 |
| Employment | |||
| (reg job, temp work, self-emp vs. other) | 1.11 | (0.87-1.41) | 0.401 |
| Unstable housing | |||
| (Yes vs. no) | 0.90 | (0.76-1.07) | 0.239 |
| Viral load | |||
| (per log10copies/mL) | 0.54 | (0.48-0.60) | <0.001 |
| CD4+ count | |||
| (per 100 cells/mm3) | 0.95 | (0.89-1.00) | 0.047 |
*Refers to the previous six-month period. †Defined as drug treatment other than methadone in the past six months. ϕGEE = Generalized Estimating Equation.